Table 1 A Comparison of Baseline Characteristics Between Men and Women With Non-Small Cell Lung Cancer, Who Underwent SurgeryContinuous variables are expressed as mean ± SD and dichotomous variables are expressed as % of column totals.
From: The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women
| Â | Men N = 388 | Women N= 222 | P value |
|---|---|---|---|
Age (years) | 64 ± 9 | 64 ± 10 | 0.432 |
BMI (kg/m2) | 26 ± 4 | 24 ± 5 | <0.001 |
PaCO2 (mm Hg) | 41 ± 8 | 40 ± 7 | <0.001 |
PaO2 (mm Hg) | 80 ± 22 | 86 ± 30 | <0.001 |
Pre-bronchodilator FEV1(% predicted) | 74 ± 19 | 85 ± 20 | <0.001 |
Post-bronchodilator FEV1 (% predicted) | 77 ± 18 | 88 ± 20 | <0.001 |
Pre-bronchodilator FVC(% predicted) | 86 ± 16 | 94 ± 18 | <0.001 |
Post-bronchodilator FVC, (% predicted) | 90 ± 15 | 96 ± 18 | <0.001 |
KCO (% predicted) | 78 ± 23 | 75 ± 22 | <0.001 |
Current Smokers (%) | 57 | 64 | 0.082 |
Pack Years of Smoking* | 45 ± 2 | 37 ± 2 | <0.001 |
Adenocarcinoma (%) | 40 | 73 | <0.001 |
Squamous cell carcinoma (%) | 57 | 24 | <0.001 |
Size of the tumors (cm) | 3.6 ± 1.3 | 2.7 ± 1.0 | 0.008 |
Upper Lobe (%) | 56 | 58 | 0.153 |
Middle Lobe or Lingula (%) | 3 | 7 | 0.153 |
Lower lobe (%) | 28 | 29 | 0.153 |
Multiple lobes (%) | 5 | 3 | 0.153 |